Diagnosis of Alzheimer's Disease Using Dual-Tree Complex Wavelet Transform, PCA, and Feed-Forward Neural Network

Deep Learning for Alzheimer's Disease Prediction: A Comprehensive Review

Alzheimer's disease (AD) is a neurological disorder that significantly impairs cognitive function, leading to memory loss and eventually death. AD progresses through three stages: early stage, mild cognitive impairment (MCI) (middle stage), and dementia. Early diagnosis of Alzheimer's disease is crucial and can improve survival rates among patients. Traditional methods for diagnosing AD through regular checkups and manual examinations are challenging. Advances in computer-aided diagnosis systems (CADs) have led to the development of various artificial intelligence and deep learning-based methods for rapid AD detection. This survey aims to explore the different modalities, feature extraction methods, datasets, machine learning techniques, and validation methods used in AD detection. We reviewed 116 relevant papers from repositories including Elsevier (45), IEEE (25), Springer (19), Wiley (6), PLOS One (5), MDPI (3), World Scientific (3), Frontiers (3), PeerJ (2), Hindawi (2), IO Press (1), and other multiple sources (2). The review is presented in tables for ease of reference, allowing readers to quickly grasp the key findings of each study. Additionally, this review addresses the challenges in the current literature and emphasizes the importance of interpretability and explainability in understanding deep learning model predictions. The primary goal is to assess existing techniques for AD identification and highlight obstacles to guide future research.

Predicting conversion from mild cognitive impairment to Alzheimer's disease: a multimodal approach

Successively predicting whether mild cognitive impairment patients will progress to Alzheimer's disease is of significant clinical relevance. This ability may provide information that can be leveraged by emerging intervention approaches and thus mitigate some of the negative effects of the disease. Neuroimaging biomarkers have gained some attention in recent years and may be useful in predicting the conversion of mild cognitive impairment to Alzheimer's disease. We implemented a novel multi-modal approach that allowed us to evaluate the potential of different imaging modalities, both alone and in different degrees of combinations, in predicting the conversion to Alzheimer's disease of mild cognitive impairment patients. We applied this approach to the imaging data from the Alzheimer's Disease Neuroimaging Initiative that is a multi-modal imaging dataset comprised of MRI, Fluorodeoxyglucose PET, Florbetapir PET and diffusion tensor imaging. We included a total of 480 mild cognitive impairment patients that were split into two groups: converted and stable. Imaging data were segmented into atlas-based regions of interest, from which relevant features were extracted for the different imaging modalities and used to construct machine-learning models to classify mild cognitive impairment patients into converted or stable, using each of the different imaging modalities independently. The models were then combined, using a simple weight fusion ensemble strategy, to evaluate the complementarity of different imaging modalities and their contribution to the prediction accuracy of the models. The single-modality findings revealed that the model, utilizing features extracted from Florbetapir PET, demonstrated the highest performance with a balanced accuracy of 83.51%. Concerning multi-modality models, not all combinations enhanced mild cognitive impairment conversion prediction. Notably, the combination of MRI with Fluorodeoxyglucose PET emerged as the most promising, exhibiting an overall improvement in predictive capabilities, achieving a balanced accuracy of 78.43%. This indicates synergy and complementarity between the two imaging modalities in predicting mild cognitive impairment conversion. These findings suggest that β-amyloid accumulation provides robust predictive capabilities, while the combination of multiple imaging modalities has the potential to surpass certain single-modality approaches. Exploring modality-specific biomarkers, we identified the brainstem as a sensitive biomarker for both MRI and Fluorodeoxyglucose PET modalities, implicating its involvement in early Alzheimer's pathology. Notably, the corpus callosum and adjacent cortical regions emerged as potential biomarkers, warranting further study into their role in the early stages of Alzheimer's disease.

An Intelligent System to Improve Diagnostic Support for Oral Squamous Cell Carcinoma

Oral squamous cell carcinoma (OSCC) is one of the most-prevalent cancer types worldwide, and it poses a serious threat to public health due to its high mortality and morbidity rates. OSCC typically has a poor prognosis, significantly reducing the chances of patient survival. Therefore, early detection is crucial to achieving a favorable prognosis by providing prompt treatment and increasing the chances of remission. Salivary biomarkers have been established in numerous studies to be a trustworthy and non-invasive alternative for early cancer detection. In this sense, we propose an intelligent system that utilizes feed-forward artificial neural networks to classify carcinoma with salivary biomarkers extracted from control and OSCC patient samples. We conducted experiments using various salivary biomarkers, ranging from 1 to 51, to train the model, and we achieved excellent results with precision, sensitivity, and specificity values of 98.53%, 96.30%, and 97.56%, respectively. Our system effectively classified the initial cases of OSCC with different amounts of biomarkers, aiding medical professionals in decision-making and providing a more-accurate diagnosis. This could contribute to a higher chance of treatment success and patient survival. Furthermore, the minimalist configuration of our model presents the potential for incorporation into resource-limited devices or environments.

Nonlinear Feature Extraction Methods Based on Dual-Tree Complex Wavelet Transform Subimages of Brain Magnetic Resonance Imaging for the Classification of Multiple Diseases

It has been a long time since we use magnetic resonance imaging (MRI) to detect brain diseases and many useful techniques have been developed for this task. However, there is still a potential for further improvement of classification of brain diseases in order to be sure of the results. In this research we presented, for the first time, a non-linear feature extraction method from the MRI sub-images that are obtained from the three levels of the two-dimensional Dual tree complex wavelet transform (2D DT-CWT) in order to classify multiple brain disease. After extracting the non-linear features from the sub-images, we used the spectral regression discriminant analysis (SRDA) algorithm to reduce the classifying features. Instead of using the deep neural networks that are computationally expensive, we proposed the Hybrid RBF network that uses the k-means and recursive least squares (RLS) algorithm simultaneously in its structure for classification. To evaluate the performance of RBF networks with hybrid learning algorithms, we classify nine brain diseases based on MRI processing using these networks, and compare the results with the previously presented classifiers including, supporting vector machines (SVM) and K-nearest neighbour (KNN). Comprehensive comparisons are made with the recently proposed cases by extracting various types and numbers of features. Our aim in this paper is to reduce the complexity and improve the classifying results with the hybrid RBF classifier and the results showed 100 percent classification accuracy in both the two class and the multiple classification of brain diseases in 8 and 10 classes. In this paper, we provided a low computational and precise method for brain MRI disease classification. the results show that the proposed method is not only accurate but also computationally reasonable.

BoF-SVM-based data intelligence model for detecting dementia

Dementia is a brain condition that impairs the cognitive abilities of an individual. Mild cognitive impairment is a mediator phase of healthy and dementia controls. The motivation of this study is to predict dementia using magnetic resonance imaging data, which is significant for the diagnosis of normal control and dementia patients. The proposed model leverages effective methods like Discrete Wavelet Transform, Bag of Features, and Support Vector Machine. The four wavelets haar, Daubechies, symlets, and coiflets are used for image compression. The results of the proposed data intelligence model are promising in terms of accuracy which is 92.32% which is better than the recently proposed models. Also, the proposed data intelligence model is compared with the models which may use curvelet transform, and shearlet transform and with the methods which have gone without using DWT transforms. The comparisons have also been made with the models that have used other prevalent techniques like Principal Component Analysis, Fisher Discriminant Ratio, and Gray Level Co-occurrence Matrix. The outcomes support the usage of each technique in the suggested data intelligence paradigm.

A review on Alzheimer's disease classification from normal controls and mild cognitive impairment using structural MR images

Alzheimer's disease (AD) is an irreversible neurodegenerative brain disorder that degrades the memory and cognitive ability in elderly people. The main reason for memory loss and reduction in cognitive ability is the structural changes in the brain that occur due to neuronal loss. These structural changes are most conspicuous in the hippocampus, cortex, and grey matter and can be assessed by using neuroimaging techniques viz. Positron Emission Tomography (PET), structural Magnetic Resonance Imaging (MRI) and functional MRI (fMRI), etc. Out of these neuroimaging techniques, structural MRI has evolved as the best technique as it indicates the best soft tissue contrast and high spatial resolution which is important for AD detection. Currently, the focus of researchers is on predicting the conversion of Mild Cognitive Impairment (MCI) into AD. MCI represents the transition state between expected cognitive changes with normal aging and Alzheimer's disease. Not every MCI patient progresses into Alzheimer's disease. MCI can develop into stable MCI (sMCI, patients are called non-converters) or into progressive MCI (pMCI, patients are diagnosed as MCI converters). This paper discusses the prognosis of MCI to AD conversion and presents a review of structural MRI-based studies for AD detection. AD detection framework includes feature extraction, feature selection, and classification process. This paper reviews the studies for AD detection based on different feature extraction methods and machine learning algorithms for classification. The performance of various feature extraction methods has been compared and it has been observed that the wavelet transform-based feature extraction method would give promising results for AD classification. The present study indicates that researchers are successful in classifying AD from Normal Controls (N_rmC) but, it still requires a lot of work to be done for MCI/ N_rmC and MCI/AD, which would help in detecting AD at its early stage.

Transfer learning-based modified inception model for the diagnosis of Alzheimer's disease

Alzheimer's disease (AD) is a neurodegenerative ailment, which gradually deteriorates memory and weakens the cognitive functions and capacities of the body, such as recall and logic. To diagnose this disease, CT, MRI, PET, etc. are used. However, these methods are time-consuming and sometimes yield inaccurate results. Thus, deep learning models are utilized, which are less time-consuming and yield results with better accuracy, and could be used with ease. This article proposes a transfer learning-based modified inception model with pre-processing methods of normalization and data addition. The proposed model achieved an accuracy of 94.92 and a sensitivity of 94.94. It is concluded from the results that the proposed model performs better than other state-of-the-art models. For training purposes, a Kaggle dataset was used comprising 6,200 images, with 896 mild demented (M.D) images, 64 moderate demented (Mod.D) images, and 3,200 non-demented (N.D) images, and 1,966 veritably mild demented (V.M.D) images. These models could be employed for developing clinically useful results that are suitable to descry announcements in MRI images.

The Application of DTCWT on MRI-Derived Radiomics for Differentiation of Glioblastoma and Solitary Brain Metastases

Background: While magnetic resonance imaging (MRI) is the imaging modality of choice for the evaluation of patients with brain tumors, it may still be challenging to differentiate glioblastoma multiforme (GBM) from solitary brain metastasis (SBM) due to their similar imaging features. This study aimed to evaluate the features extracted of dual-tree complex wavelet transform (DTCWT) from routine MRI protocol for preoperative differentiation of glioblastoma (GBM) and solitary brain metastasis (SBM). Methods: A total of 51 patients were recruited, including 27 GBM and 24 SBM patients. Their contrast-enhanced T1-weighted images (CET1WIs), T2 fluid-attenuated inversion recovery (T2FLAIR) images, diffusion-weighted images (DWIs), and apparent diffusion coefficient (ADC) images were employed in this study. The statistical features of the pre-transformed images and the decomposed images of the wavelet transform and DTCWT were utilized to distinguish between GBM and SBM. Results: The support vector machine (SVM) showed that DTCWT images have a better accuracy (82.35%), sensitivity (77.78%), specificity (87.50%), and the area under the curve of the receiver operating characteristic curve (AUC) (89.20%) than the pre-transformed and conventional wavelet transform images. By incorporating DTCWT and pre-transformed images, the accuracy (86.27%), sensitivity (81.48%), specificity (91.67%), and AUC (93.06%) were further improved. Conclusions: Our studies suggest that the features extracted from the DTCWT images can potentially improve the differentiation between GBM and SBM.

HTLML: Hybrid AI Based Model for Detection of Alzheimer’s Disease

Alzheimer’s disease (AD) is a degenerative condition of the brain that affects the memory and reasoning abilities of patients. Memory is steadily wiped out by this condition, which gradually affects the brain’s ability to think, recall, and form intentions. In order to properly identify this disease, a variety of manual imaging modalities including CT, MRI, PET, etc. are being used. These methods, however, are time-consuming and troublesome in the context of early diagnostics. This is why deep learning models have been devised that are less time-intensive, require less high-tech hardware or human interaction, continue to improve in performance, and are useful for the prediction of AD, which can also be verified by experimental results obtained by doctors in medical institutions or health care facilities. In this paper, we propose a hybrid-based AI-based model that includes the combination of both transfer learning (TL) and permutation-based machine learning (ML) voting classifier in terms of two basic phases. In the first phase of implementation, it comprises two TL-based models: namely, DenseNet-121 and Densenet-201 for features extraction, whereas in the second phase of implementation, it carries out three different ML classifiers like SVM, Naïve base and XGBoost for classification purposes. The final classifier outcomes are evaluated by means of permutations of the voting mechanism. The proposed model achieved accuracy of 91.75%, specificity of 96.5%, and an F1-score of 90.25. The dataset used for training was obtained from Kaggle and contains 6200 photos, including 896 images classified as mildly demented, 64 images classified as moderately demented, 3200 images classified as non-demented, and 1966 images classified as extremely mildly demented. The results show that the suggested model outperforms current state-of-the-art models. These models could be used to generate therapeutically viable methods for detecting AD in MRI images based on these results for clinical prospective.

Probabilistic principal component analysis and long short-term memory classifier for automatic detection of Alzheimer’s disease using MRI brain images

The automatic recognition and classification of Alzheimer disease utilizing magnetic resonance imaging is a hard task, due to the complexity and variability of the size, location, texture and shape of the lesions. The objective of this study is to propose a proper feature dimensional reduction and classification approach to improve the performance of Alzheimer disease recognition and classification. At first, the input brain images were acquired from Open Access Series of Imaging Studies (OASIS) and National Institute of Mental Health and Neuro Sciences (NIMHANS) databases. Then, the image pre-processing and feature extraction were attained by applying Contrast Limited Adaptive Histogram Equalization (CLAHE) and Discrete Wavelet Transform (DWT) approach to denoise and extract the feature vectors from the images. In addition, Probabilistic Principal Component Analysis (PPCA) was used to diminish the extracted features dimension that effectively lessen the “curse of dimensionality” concern. At last, Long Short-Term Memory (LSTM) classifier was employed to classify the brain images as Alzheimer disease, normal, and Mild Cognitive Impairment (MCI). From the simulation outcome, the proposed system attained better performance compared to the existing systems and showed 3–11% improvement in recognition accuracy.

A Precise Medical Imaging Approach for Brain MRI Image Classification

Magnetic resonance imaging (MRI) is an accurate and noninvasive method employed for the diagnosis of various kinds of diseases in medical imaging. Most of the existing systems showed significant performances on small MRI datasets, while their performances decrease against large MRI datasets. Hence, the goal was to design an efficient and robust classification system that sustains a high recognition rate against large MRI dataset. Accordingly, in this study, we have proposed the usage of a novel feature extraction technique that has the ability to extract and select the prominent feature from MRI image. The proposed algorithm selects the best features from the MRI images of various diseases. Further, this approach discriminates various classes based on recursive values such as partial Z-value. The proposed approach only extracts a minor feature set through, respectively, forward and backward recursion models. The most interrelated features are nominated in the forward regression model that depends on the values of partial Z-test, while the minimum interrelated features are diminished from the corresponding feature space under the presence of the backward model. In both cases, the values of Z-test are estimated through the defined labels of the diseases. The proposed model is efficiently looking the localized features, which is one of the benefits of this method. After extracting and selecting the best features, the model is trained by utilizing support vector machine (SVM) to provide the predicted labels to the corresponding MRI images. To show the significance of the proposed model, we utilized a publicly available standard dataset such as Harvard Medical School and Open Access Series of Imaging Studies (OASIS), which contains 24 various brain diseases including normal. The proposed approach achieved the best classification accuracy against existing state-of-the-art systems.

A computer-aided diagnosis system for the classification of COVID-19 and non-COVID-19 pneumonia on chest X-ray images by integrating CNN with sparse autoencoder and feed forward neural network

Several infectious diseases have affected the lives of many people and have caused great dilemmas all over the world. COVID-19 was declared a pandemic caused by a newly discovered virus named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by the World Health Organisation in 2019. RT-PCR is considered the golden standard for COVID-19 detection. Due to the limited RT-PCR resources, early diagnosis of the disease has become a challenge. Radiographic images such as Ultrasound, CT scans, X-rays can be used for the detection of the deathly disease. Developing deep learning models using radiographic images for detecting COVID-19 can assist in countering the outbreak of the virus. This paper presents a computer-aided detection model utilizing chest X-ray images for combating the pandemic. Several pre-trained networks and their combinations have been used for developing the model. The method uses features extracted from pre-trained networks along with Sparse autoencoder for dimensionality reduction and a Feed Forward Neural Network (FFNN) for the detection of COVID-19. Two publicly available chest X-ray image datasets, consisting of 504 COVID-19 images and 542 non-COVID-19 images, have been combined to train the model. The method was able to achieve an accuracy of 0.9578 and an AUC of 0.9821, using the combination of InceptionResnetV2 and Xception. Experiments have proved that the accuracy of the model improves with the usage of sparse autoencoder as the dimensionality reduction technique.

3D shearlet-based descriptors combined with deep features for the classification of Alzheimer's disease based on MRI data

Alzheimer's disease (AD) is a neurodegenerative disease that afflicts millions of people worldwide. Early detection of AD is critical, as drug trials show a promising advantage to those patients with early diagnoses. In this study, magnetic resonance imaging (MRI) datasets from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and The Open Access Series of Imaging Studies are used. Our method for performing the classification of AD is to combine a set of shearlet-based descriptors with deep features. A major challenge in classifying such MRI datasets is the high dimensionality of feature vectors because of the large number of slices of each MRI sample. Given the volumetric nature of the MRI data, we propose using the 3D shearlet transform (3D-ST), but we obtain the average of all directionalities, which reduces the dimensionality. On the other hand, we propose to leverage the capabilities of convolutional neural networks (CNN) to learn feature maps from stacked MRI slices, which generate a very compact feature vector for each MRI sample. The 3D-ST and CNN feature vectors are combined for the classification of AD. After the concatenation of the feature vectors, they are used to train a classifier. Alternatively, a custom CNN model is utilized, in which the descriptors are further processed end to end to obtain the classification model. Our experimental results show that the fusion of shearlet-based descriptors and deep features improves classification performance, especially on the ADNI dataset.

Deep Convolutional Neural Networks With Ensemble Learning and Generative Adversarial Networks for Alzheimer's Disease Image Data Classification

Recent advancements in deep learning (DL) have made possible new methodologies for analyzing massive datasets with intriguing implications in healthcare. Convolutional neural networks (CNN), which have proven to be successful supervised algorithms for classifying imaging data, are of particular interest in the neuroscience community for their utility in the classification of Alzheimer's disease (AD). AD is the leading cause of dementia in the aging population. There remains a critical unmet need for early detection of AD pathogenesis based on non-invasive neuroimaging techniques, such as magnetic resonance imaging (MRI) and positron emission tomography (PET). In this comprehensive review, we explore potential interdisciplinary approaches for early detection and provide insight into recent advances on AD classification using 3D CNN architectures for multi-modal PET/MRI data. We also consider the application of generative adversarial networks (GANs) to overcome pitfalls associated with limited data. Finally, we discuss increasing the robustness of CNNs by combining them with ensemble learning (EL).

Classification of Alzheimer's disease using ensemble of deep neural networks trained through transfer learning

Deep learning; transfer learning; ensemble learning; Alzheimer's disease.

MRI Radiomics Classification and Prediction in Alzheimer's Disease and Mild Cognitive Impairment: A Review

BACKGROUND

Alzheimer's Disease (AD) is a progressive neurodegenerative disease that threatens the health of the elderly. Mild Cognitive Impairment (MCI) is considered to be the prodromal stage of AD. To date, AD or MCI diagnosis is established after irreversible brain structure alterations. Therefore, the development of new biomarkers is crucial to the early detection and treatment of this disease. At present, there exist some research studies showing that radiomics analysis can be a good diagnosis and classification method in AD and MCI.

OBJECTIVE

An extensive review of the literature was carried out to explore the application of radiomics analysis in the diagnosis and classification among AD patients, MCI patients, and Normal Controls (NCs).

RESULTS

Thirty completed MRI radiomics studies were finally selected for inclusion. The process of radiomics analysis usually includes the acquisition of image data, Region of Interest (ROI) segmentation, feature extracting, feature selection, and classification or prediction. From those radiomics methods, texture analysis occupied a large part. In addition, the extracted features include histogram, shapebased features, texture-based features, wavelet features, Gray Level Co-Occurrence Matrix (GLCM), and Run-Length Matrix (RLM).

CONCLUSION

Although radiomics analysis is already applied to AD and MCI diagnosis and classification, there still is a long way to go from these computer-aided diagnostic methods to the clinical application.

Alzheimer's disease detection using depthwise separable convolutional neural networks

To diagnose Alzheimer's disease (AD), neuroimaging methods such as magnetic resonance imaging have been employed. Recent progress in computer vision with deep learning (DL) has further inspired research focused on machine learning algorithms. However, a few limitations of these algorithms, such as the requirement for large number of training images and the necessity for powerful computers, still hinder the extensive usage of AD diagnosis based on machine learning. In addition, large number of training parameters and heavy computation make the DL systems difficult in integrating with mobile embedded devices, for example the mobile phones. For AD detection using DL, most of the current research solely focused on improving the classification performance, while few studies have been done to obtain a more compact model with less complexity and relatively high recognition accuracy. In order to solve this problem and improve the efficiency of the DL algorithm, a deep separable convolutional neural network model is proposed for AD classification in this paper. The depthwise separable convolution (DSC) is used in this work to replace the conventional convolution. Compared to the traditional neural networks, the parameters and computing cost of the proposed neural network are found greatly reduced. The parameters and computational costs of the proposed neural network are found to be significantly reduced compared with conventional neural networks. With its low power consumption, the proposed model is particularly suitable for embedding mobile devices. Experimental findings show that the DSC algorithm, based on the OASIS magnetic resonance imaging dataset, is very successful for AD detection. Moreover, transfer learning is employed in this work to improve model performance. Two trained models with complex networks, namely AlexNet and GoogLeNet, are used for transfer learning, with average classification rates of 91.40%, 93.02% and a less power consumption.

Diagnosis of Alzheimer's Disease in Developed and Developing Countries: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy

BACKGROUND

The present systematic review and meta-analysis of diagnostic test accuracy summarizes the last three decades in advances on diagnosis of Alzheimer's disease (AD) in developed and developing countries.

OBJECTIVE

To determine the accuracy of biomarkers in diagnostic tools in AD, for example, cerebrospinal fluid, positron emission tomography (PET), and magnetic resonance imaging (MRI), etc.

METHODS

The authors searched PubMed for published studies from 1990 to April 2020 on AD diagnostic biomarkers. 84 published studies were pooled and analyzed in this meta-analysis and diagnostic accuracy was compared by summary receiver operating characteristic statistics.

RESULTS

Overall, 84 studies met the criteria and were included in a meta-analysis. For EEG, the sensitivity ranged from 67 to 98%, with a median of 80%, 95% CI [75, 91], tau-PET diagnosis sensitivity ranged from 76 to 97%, with a median of 94%, 95% CI [76, 97]; and MRI sensitivity ranged from 41 to 99%, with a median of 84%, 95% CI [81, 87]. Our results showed that tau-PET diagnosis had higher performance as compared to other diagnostic methods in this meta-analysis.

CONCLUSION

Our findings showed an important discrepancy in diagnostic data for AD between developed and developing countries, which can impact global prevalence estimation and management of AD. Also, our analysis found a better performance for the tau-PET diagnostic over other methods to diagnose AD patients, but the expense of tau-PET scan seems to be the limiting factor in the diagnosis of AD in developing countries such as those found in Asia, Africa, and Latin America.

MRI Segmentation and Classification of Human Brain Using Deep Learning for Diagnosis of Alzheimer's Disease: A Survey

Many neurological diseases and delineating pathological regions have been analyzed, and the anatomical structure of the brain researched with the aid of magnetic resonance imaging (MRI). It is important to identify patients with Alzheimer's disease (AD) early so that preventative measures can be taken. A detailed analysis of the tissue structures from segmented MRI leads to a more accurate classification of specific brain disorders. Several segmentation methods to diagnose AD have been proposed with varying complexity. Segmentation of the brain structure and classification of AD using deep learning approaches has gained attention as it can provide effective results over a large set of data. Hence, deep learning methods are now preferred over state-of-the-art machine learning methods. We aim to provide an outline of current deep learning-based segmentation approaches for the quantitative analysis of brain MRI for the diagnosis of AD. Here, we report how convolutional neural network architectures are used to analyze the anatomical brain structure and diagnose AD, discuss how brain MRI segmentation improves AD classification, describe the state-of-the-art approaches, and summarize their results using publicly available datasets. Finally, we provide insight into current issues and discuss possible future research directions in building a computer-aided diagnostic system for AD.

Convolutional neural networks for classification of Alzheimer's disease: Overview and reproducible evaluation

Numerous machine learning (ML) approaches have been proposed for automatic classification of Alzheimer's disease (AD) from brain imaging data. In particular, over 30 papers have proposed to use convolutional neural networks (CNN) for AD classification from anatomical MRI. However, the classification performance is difficult to compare across studies due to variations in components such as participant selection, image preprocessing or validation procedure. Moreover, these studies are hardly reproducible because their frameworks are not publicly accessible and because implementation details are lacking. Lastly, some of these papers may report a biased performance due to inadequate or unclear validation or model selection procedures. In the present work, we aim to address these limitations through three main contributions. First, we performed a systematic literature review. We identified four main types of approaches: i) 2D slice-level, ii) 3D patch-level, iii) ROI-based and iv) 3D subject-level CNN. Moreover, we found that more than half of the surveyed papers may have suffered from data leakage and thus reported biased performance. Our second contribution is the extension of our open-source framework for classification of AD using CNN and T1-weighted MRI. The framework comprises previously developed tools to automatically convert ADNI, AIBL and OASIS data into the BIDS standard, and a modular set of image preprocessing procedures, classification architectures and evaluation procedures dedicated to deep learning. Finally, we used this framework to rigorously compare different CNN architectures. The data was split into training/validation/test sets at the very beginning and only the training/validation sets were used for model selection. To avoid any overfitting, the test sets were left untouched until the end of the peer-review process. Overall, the different 3D approaches (3D-subject, 3D-ROI, 3D-patch) achieved similar performances while that of the 2D slice approach was lower. Of note, the different CNN approaches did not perform better than a SVM with voxel-based features. The different approaches generalized well to similar populations but not to datasets with different inclusion criteria or demographical characteristics. All the code of the framework and the experiments is publicly available: general-purpose tools have been integrated into the Clinica software (www.clinica.run) and the paper-specific code is available at: https://github.com/aramis-lab/AD-DL.

Single-slice Alzheimer's disease classification and disease regional analysis with Supervised Switching Autoencoders

BACKGROUND

Alzheimer's disease (AD) is a difficult to diagnose pathology of the brain that progressively impairs cognitive functions. Computer-assisted diagnosis of AD based on image analysis is an emerging tool to support AD diagnosis. In this article, we explore the application of Supervised Switching Autoencoders (SSAs) to perform AD classification using only one structural Magnetic Resonance Imaging (sMRI) slice. SSAs are revised supervised autoencoder architectures, combining unsupervised representation and supervised classification as one unified model. In this work, we study the capabilities of SSAs to capture complex visual neurodegeneration patterns, and fuse disease semantics simultaneously. We also examine how regions associated to disease state can be discovered by SSAs following a local patch-based approach.

METHODS

Patch-based SSAs models are trained on individual patches extracted from a single 2D slice, independently for Axial, Coronal, and Sagittal anatomical planes of the brain at selected informative locations, exploring different patch sizes and network parameterizations. Then, models perform binary class prediction - healthy (CDR = 0) or AD-demented (CDR > 0) - on test data at patch level. The final subject classification is performed employing a majority rule from the ensemble of patch predictions. In addition, relevant regions are identified, by computing accuracy densities from patch-level predictions, and analyzed, supported by Atlas-based regional definitions.

RESULTS

Our experiments employing a single 2D T1-w sMRI slice per subject show that SSAs perform similarly to previous proposals that rely on full volumetric information and feature-engineered representations. SSAs classification accuracy on slices extracted along the Axial, Coronal, and Sagittal anatomical planes from a balanced cohort of 40 independent test subjects was 87.5%, 90.0%, and 90.0%, respectively. A top sensitivity of 95.0% on both Coronal and Sagittal planes was also obtained.

CONCLUSIONS

SSAs provided well-ranked accuracy performance among previous classification proposals, including feature-engineered and feature learning based methods, using only one scan slice per subject, instead of the whole 3D volume, as it is conventionally done. In addition, regions identified as relevant by SSAs' were, in most part, coherent or partially coherent in regard to relevant regions reported on previous works. These regions were also associated with findings from medical knowledge, which gives value to our methodology as a potential analytical aid for disease understanding.

Automated Breast Cancer Diagnosis Based on Machine Learning Algorithms

There have been several empirical studies addressing breast cancer using machine learning and soft computing techniques. Many claim that their algorithms are faster, easier, or more accurate than others are. This study is based on genetic programming and machine learning algorithms that aim to construct a system to accurately differentiate between benign and malignant breast tumors. The aim of this study was to optimize the learning algorithm. In this context, we applied the genetic programming technique to select the best features and perfect parameter values of the machine learning classifiers. The performance of the proposed method was based on sensitivity, specificity, precision, accuracy, and the roc curves. The present study proves that genetic programming can automatically find the best model by combining feature preprocessing methods and classifier algorithms.

Prediction and Classification of Alzheimer's Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers

Alzheimer's disease (AD), including its mild cognitive impairment (MCI) phase that may or may not progress into the AD, is the most ordinary form of dementia. It is extremely important to correctly identify patients during the MCI stage because this is the phase where AD may or may not develop. Thus, it is crucial to predict outcomes during this phase. Thus far, many researchers have worked on only using a single modality of a biomarker for the diagnosis of AD or MCI. Although recent studies show that a combination of one or more different biomarkers may provide complementary information for the diagnosis, it also increases the classification accuracy distinguishing between different groups. In this paper, we propose a novel machine learning-based framework to discriminate subjects with AD or MCI utilizing a combination of four different biomarkers: fluorodeoxyglucose positron emission tomography (FDG-PET), structural magnetic resonance imaging (sMRI), cerebrospinal fluid (CSF) protein levels, and Apolipoprotein-E (APOE) genotype. The Alzheimer's Disease Neuroimaging Initiative (ADNI) baseline dataset was used in this study. In total, there were 158 subjects for whom all four modalities of biomarker were available. Of the 158 subjects, 38 subjects were in the AD group, 82 subjects were in MCI groups (including 46 in MCIc [MCI converted; conversion to AD within 24 months of time period], and 36 in MCIs [MCI stable; no conversion to AD within 24 months of time period]), and the remaining 38 subjects were in the healthy control (HC) group. For each image, we extracted 246 regions of interest (as features) using the Brainnetome template image and NiftyReg toolbox, and later we combined these features with three CSF and two APOE genotype features obtained from the ADNI website for each subject using early fusion technique. Here, a different kernel-based multiclass support vector machine (SVM) classifier with a grid-search method was applied. Before passing the obtained features to the classifier, we have used truncated singular value decomposition (Truncated SVD) dimensionality reduction technique to reduce high dimensional features into a lower-dimensional feature. As a result, our combined method achieved an area under the receiver operating characteristic (AU-ROC) curve of 98.33, 93.59, 96.83, 94.64, 96.43, and 95.24% for AD vs. HC, MCIs vs. MCIc, AD vs. MCIs, AD vs. MCIc, HC vs. MCIc, and HC vs. MCIs subjects which are high relative to single modality results and other state-of-the-art approaches. Moreover, combined multimodal methods have improved the classification performance over the unimodal classification.

Pixel-Label-Based Segmentation of Cross-Sectional Brain MRI Using Simplified SegNet Architecture-Based CNN

Using deep neural networks for segmenting an MRI image of heterogeneously distributed pixels into a specific class assigning a label to each pixel is the concept of the proposed approach. This approach facilitates the application of the segmentation process on a preprocessed MRI image, with a trained network to be utilized for other test images. As labels are considered expensive assets in supervised training, fewer training images and training labels are used to obtain optimal accuracy. To validate the performance of the proposed approach, an experiment is conducted on other test images (available in the same database) that are not part of the training; the obtained result is of good visual quality in terms of segmentation and quite similar to the ground truth image. The average computed Dice similarity index for the test images is approximately 0.8, whereas the Jaccard similarity measure is approximately 0.6, which is better compared to other methods. This implies that the proposed method can be used to obtain reference images almost similar to the segmented ground truth images.

Pathological Brain Detection Using Weiner Filtering, 2D-Discrete Wavelet Transform, Probabilistic PCA, and Random Subspace Ensemble Classifier

Accurate diagnosis of pathological brain images is important for patient care, particularly in the early phase of the disease. Although numerous studies have used machine-learning techniques for the computer-aided diagnosis (CAD) of pathological brain, previous methods encountered challenges in terms of the diagnostic efficiency owing to deficiencies in the choice of proper filtering techniques, neuroimaging biomarkers, and limited learning models. Magnetic resonance imaging (MRI) is capable of providing enhanced information regarding the soft tissues, and therefore MR images are included in the proposed approach. In this study, we propose a new model that includes Wiener filtering for noise reduction, 2D-discrete wavelet transform (2D-DWT) for feature extraction, probabilistic principal component analysis (PPCA) for dimensionality reduction, and a random subspace ensemble (RSE) classifier along with the K-nearest neighbors (KNN) algorithm as a base classifier to classify brain images as pathological or normal ones. The proposed methods provide a significant improvement in classification results when compared to other studies. Based on 5 × 5 cross-validation (CV), the proposed method outperforms 21 state-of-the-art algorithms in terms of classification accuracy, sensitivity, and specificity for all four datasets used in the study.